QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking

Abstract VEGFR-2 kinase inhibitors are clinically approved drugs that can effectively target cancer angiogenesis. However, such inhibitors have adverse effects such as skin toxicity, gastrointestinal reactions and hepatic impairment. In this study, machine learning and Topomer CoMFA, which is an alignment-dependent, descriptor-based method, were employed to build structural activity relationship models of potentially new VEGFR-2 inhibitors. The prediction ac-curacy of the training and test sets of the 2D-SAR model were 82.4 and 80.1%, respectively, with KNN. Topomer CoMFA approach was then used for 3D-QSAR modeling of VEGFR-2 inhibitors. The coefficient of q2 for cross-validation of the model 1 was greater than 0.5, suggesting that a stable drug activity-prediction model was obtained. Molecular docking was further performed to simulate the interactions between the five most promising compounds and VEGFR-2 target protein and the Total Scores were all greater than 6, indicating that they had a strong hydrogen bond interactions were present. This study successfully used machine learning to obtain five potentially novel VEGFR-2 inhibitors to increase our arsenal of drugs to combat cancer..

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

BMC chemistry - 18(2024), 1 vom: 30. März

Sprache:

Englisch

Beteiligte Personen:

Ding, Hao [VerfasserIn]
Xing, Fei [VerfasserIn]
Zou, Lin [VerfasserIn]
Zhao, Liang [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Machine learning
Molecular docking
Structure–activity relationship model
VEGFR-2

Anmerkungen:

© The Author(s) 2024

doi:

10.1186/s13065-024-01165-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR055358977